Optivolt

📍 San Francisco, United States🗓 Founded 2017👥 30 employees💰 Last funded Jul 2021
Optivolt is driving global energy abundance through breakthroughs in solar power electronics. The Problem: Despite its potential, solar supplies just 5% of global energy—limited by fundamental technical barriers. Minor shading can reduce power output by 90%, while systems remain bulky, expensive, time-consuming to install, and prone to failure. Optivolts Breakthrough: We realized deep integration between solar panels and power electronics unlocks an entirely new design space for innovation. This led us to inventing the Balancer (8 patents issued, 27 pending), an advanced power electronics device which embeds inside solar panels. Balancers work by shuffling power from stronger to weaker zones in the panel to keep power flowing, maximizing energy output and reliability. Performance vs. $8B market leader: • Up to 6x higher power output in real-world conditions • 40% lower equipment cost, 50% faster to install • 4x less failure points, while eliminating hotspots (#1 solar failure mode) Balancers cut the cost of solar by up to 40%, which for the first time, makes solar cheaper than the grid—everywhere. Recognizing the impact, the U.S. Department of Energy is participating in funding of Optivolt’s development.
4
Total investors
2
Early stage
2
Mid stage
0
Late stage
2017
Founded
Investor geography1 country
United States
4
Investor activity2018–2021 · investors recorded per year
201812019120212
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Optivolt?
Optivolt has 4 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage.
When did Optivolt last raise funding?
The most recent investment in Optivolt recorded on gritt.io was in July 2021.
When was Optivolt founded?
Optivolt was founded in 2017.
What industry is Optivolt in?
Optivolt operates in Energy Technology. Find similar Energy Technology investors on gritt.io.
Where is Optivolt based?
Optivolt is headquartered in San Francisco, United States.